185 related articles for article (PubMed ID: 23720012)
1. DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome.
; Savige J; Ars E; Cotton RG; Crockett D; Dagher H; Deltas C; Ding J; Flinter F; Pont-Kingdon G; Smaoui N; Torra R; Storey H
Pediatr Nephrol; 2014 Jun; 29(6):971-7. PubMed ID: 23720012
[TBL] [Abstract][Full Text] [Related]
2. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
[TBL] [Abstract][Full Text] [Related]
3. The Alport syndrome COL4A5 variant database.
Crockett DK; Pont-Kingdon G; Gedge F; Sumner K; Seamons R; Lyon E
Hum Mutat; 2010 Aug; 31(8):E1652-7. PubMed ID: 20574986
[TBL] [Abstract][Full Text] [Related]
4. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome.
Gibson JT; Huang M; Shenelli Croos Dabrera M; Shukla K; Rothe H; Hilbert P; Deltas C; Storey H; Lipska-Ziętkiewicz BS; Chan MMY; Sadeghi-Alavijeh O; Gale DP; ; Cerkauskaite A; Savige J
Sci Rep; 2022 Feb; 12(1):2722. PubMed ID: 35177655
[TBL] [Abstract][Full Text] [Related]
6. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
7. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
Malone AF; Funk SD; Alhamad T; Miner JH
Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
[TBL] [Abstract][Full Text] [Related]
8. X-Linked Glomerulopathy Due to COL4A5 Founder Variant.
Barua M; John R; Stella L; Li W; Roslin NM; Sharif B; Hack S; Lajoie-Starkell G; Schwaderer AL; Becknell B; Wuttke M; Köttgen A; Cattran D; Paterson AD; Pei Y
Am J Kidney Dis; 2018 Mar; 71(3):441-445. PubMed ID: 29198386
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity of missense variants affecting the collagen IV α5 carboxy non-collagenous domain in X-linked Alport syndrome.
Gibson JT; Sadeghi-Alavijeh O; Gale DP; Rothe H; ; Savige J
Sci Rep; 2022 Jul; 12(1):11257. PubMed ID: 35789182
[TBL] [Abstract][Full Text] [Related]
10. Reassessing the pathogenicity of c.2858G>T(p.(G953V)) in COL4A5 Gene: report of 19 Chinese families.
Zhang Y; Ding J; Wang S; Zhang H; Zhong X; Liu X; Xu K; Wang F
Eur J Hum Genet; 2020 Feb; 28(2):244-252. PubMed ID: 31576025
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay.
Horinouchi T; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Ishimori S; Kaito H; Matsuo M; Iijima K; Nozu K
Mol Genet Genomic Med; 2020 Aug; 8(8):e1342. PubMed ID: 32543079
[TBL] [Abstract][Full Text] [Related]
12. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts.
Wang F; Wang Y; Ding J; Yang J
Kidney Int; 2005 Apr; 67(4):1268-74. PubMed ID: 15780079
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome.
Helle OMB; Pedersen TH; Ousager LB; Thomassen M; Hertz JM
Mol Genet Genomic Med; 2020 Oct; 8(10):e1452. PubMed ID: 32812400
[TBL] [Abstract][Full Text] [Related]
14. Expert consensus guidelines for the genetic diagnosis of Alport syndrome.
Savige J; Ariani F; Mari F; Bruttini M; Renieri A; Gross O; Deltas C; Flinter F; Ding J; Gale DP; Nagel M; Yau M; Shagam L; Torra R; Ars E; Hoefele J; Garosi G; Storey H
Pediatr Nephrol; 2019 Jul; 34(7):1175-1189. PubMed ID: 29987460
[TBL] [Abstract][Full Text] [Related]
15. Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central/East Europe and causes kidney failure in midlife.
Żurowska AM; Bielska O; Daca-Roszak P; Jankowski M; Szczepańska M; Roszkowska-Bjanid D; Kuźma-Mroczkowska E; Pańczyk-Tomaszewska M; Moczulska A; Drożdż D; Hadjipanagi D; Deltas C; Ostalska-Nowicka D; Rabiega A; Taraszkiewicz J; Taranta-Janusz K; Wieczorkiewicz-Plaza A; Jobs K; Mews J; Musiał K; Jakubowska A; Nosek H; Jander AE; Koutsofti C; Stanisławska-Sachadyn A; Kuleszo D; Ziętkiewicz E; Lipska-Ziętkiewicz BS
Kidney Int; 2021 Jun; 99(6):1451-1458. PubMed ID: 33309955
[TBL] [Abstract][Full Text] [Related]
16. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.
Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L
Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316
[TBL] [Abstract][Full Text] [Related]
17. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
[TBL] [Abstract][Full Text] [Related]
18. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
[TBL] [Abstract][Full Text] [Related]
19. Female X-linked Alport syndrome with somatic mosaicism.
Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
[TBL] [Abstract][Full Text] [Related]
20. Improved genetic counseling in Alport syndrome by new variants of COL4A5 gene.
Fernandez-Rosado F; Campos A; Alvarez-Cubero MJ; Ruiz A; Entrala-Bernal C
Nephrology (Carlton); 2015 Jul; 20(7):502-5. PubMed ID: 26063487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
